Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux, Singapore Invest $2.2M to Research TB Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institut Mérieux, its in vitro diagnostics firm BioMérieux, and the Singapore government are investing S$3 million ($2.2 million) to investigate biomarkers to identify individuals who may be at risk for developing tuberculosis and to help guide drug therapies.

As part of the project, a joint laboratory is being created at Biopolis, a scientific R&D hub located in Singapore. There, researchers from BioMérieux and Singapore's Agency for Science, Technology, and Research's Singapore Immunology Network, or SIgN, will study the immune cells in the blood of patients infected with TB but whose disease is inactive. The cells will be compared with those of patients who have active TB and those of healthy controls in order to identify potential biomarkers for TB infection and TB re-activation.

In addition to aiding in the diagnosis of the disease, the research could help clinicians assess and monitor patient response to TB treatment and manage those who have developed drug-resistance to Mycobacterium tuberculosis, SIgN said in a statement.

More than 2 billion people worldwide, nearly one-third of the population, are infected with M. tuberculosis, and about 10 percent of these will develop the disease eventually, SIgN said.

"There is an urgent need to understand and find new ways to eradicate the disease — through prediction, early detection, and effective treatment — and this timely collaboration seeks to accomplish exactly that," Paola Castagnoli, scientific director of SIgN and one of the lead researchers in the project, said in a statement.

The Scan

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.